CDDO-3P-Im |
| Catalog No.GC39556 |
Le CDDO-3P-Im est un analogue du CDDO-Imidazolide À effet chimiopréventif. CDDO-3P-Im peut réduire la taille et la gravité des tumeurs pulmonaires dans le modèle de cancer du poumon chez la souris. CDDO-3P-Im est un inhibiteur de la nécroptose actif par voie orale qui peut être utilisé pour la recherche de l'ischémie/reperfusion (I/R).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1883650-95-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CDDO-3P-Im is an analogue of CDDO-Imidazolide with chemopreventive effect. CDDO-3P-Im can reduce the size and the severity of the lung tumors in mouse lung cancer model [1].
[1]. Cao M , et al. Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention. Pharmacol Res. 2015 Oct;100:135-47.
Average Rating: 5 (Based on Reviews and 6 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *